WE NEED YOUR HELP: Help Keep The Phage Therapy Free and Independent

-

When we created The Phage Therapy in 2025, our goal was simple: make reliable information about bacteriophages and phage therapy easier to find, understand and access.

What started as a scientific information website has grown into something much larger.

Today, researchers, clinicians, students, biotechnology professionals and people interested in bacteriophages visit The Phage Therapy from around the world. More than 103,000 visits have now been recorded since the beginning of the project.

And the growth is accelerating.

Last month, The Phage Therapy received almost 14,000 visits.

This month, we have already passed 22,500.

Our current traffic is now approaching an average of 900 visits every day.

For a website dedicated to such a specialized scientific field, these numbers mean a lot to us. They show that there is a real need for a place where information about bacteriophages can be gathered, explained and made accessible.

But we want to grow without changing what made this project useful in the first place.

The Phage Therapy has no advertising.

We do not want intrusive pop-ups covering scientific articles. We do not want readers to face a paywall before accessing information. Our newsletter remains free. We are strengthening the protection of user information, and we refuse to build our audience around misleading headlines or exaggerated claims simply because they generate more clicks.

We know that scientific communication must remain accurate, particularly in a field as rapidly developing as phage therapy. We will not always be perfect, but accuracy, transparency and correction of mistakes will remain priorities.

At the same time, The Phage Therapy is no longer just a news website.

We are developing an ecosystem of six interconnected resources: PhageAtlas®, PhageTrials®, PhageAtLabs®, PhageJobs®, WikiPhage® and MyPhage®.

Each addresses a different part of the bacteriophage ecosystem, from biotechnology companies and clinical trials to research laboratories, employment opportunities and educational resources.

One of our biggest current projects is PhageAtLabs®.

Its objective is to map academic laboratories, universities, institutes and research teams working with bacteriophages around the world.

We want students to be able to discover laboratories working in their field. We want researchers to identify potential collaborators. We want scientists entering the phage community to understand where research is happening and who is working on what.

We hope to bring PhageAtLabs online around Christmas.

But building these resources takes time.

Laboratories have to be identified and checked individually. Research areas have to be verified. Databases have to be maintained. Articles have to be read, compared and written. Clinical trials and job opportunities have to be followed. The website itself has to be developed and maintained.

Behind every page and every tool is real work from our team.

Until now, much of that work and many of the costs associated with the project have been supported internally.

We would like to keep one principle unchanged:

The Phage Therapy should remain free to access.

That is why we are asking for your help.

If one of our articles has helped you discover a study, if PhageJobs helped you find an opportunity, if one of our databases saved you research time, or if The Phage Therapy simply helped you understand this field a little better, you can now support the project through Ko-fi.

Support The Phage Therapy: https://ko-fi.com/thephagetherapy

There is no obligation to contribute, and there is no contribution too small to matter.

A donation helps us maintain the website, continue developing our free tools, expand our databases and keep producing scientific content without turning The Phage Therapy into a website filled with advertising, pop-ups or paid access.

Most importantly, it helps preserve the kind of platform we want to build.

Independent.

Accessible.

Scientifically serious.

International.

And free.

More than 100,000 visits tell us that people are using what we have built.

Nearly 900 visits every day tell us that the community is growing.

Now we want to make the platform better.

If The Phage Therapy has ever helped you, and if you want to help us continue this work, you can support us here: https://ko-fi.com/thephagetherapy

And if you cannot contribute financially, sharing our work, following the project, sending us new research, suggesting laboratories for PhageAtLabs or simply telling someone about The Phage Therapy also helps enormously.

Thank you for being part of this project.

We still have a lot to build.

Comments

Post a Comment

Most Consulted Articles

Bacteriophages Disarm Inflammation-Associated E. coli Without Erasing the Gut Microbiome in IBD

-
Image
Inflammatory bowel disease is usually described through the language of immune dysregulation, chronic inflammation and genetic susceptibility. Yet an increasingly important part of the disease may lie in a more dynamic layer of biology: not simply which microorganisms inhabit the intestine, but what particular bacterial populations are doing inside it. A new study from McMaster University pushes this idea toward a striking therapeutic possibility. Instead of broadly eliminating bacteria associated with disease, bacteriophages may be used to selectively suppress the bacterial traits that help drive inflammation. McMaster researchers, from left, Kyle Jackson, Zeinab Hosseinidoust and Elena Verdu, have found a way to disarm harmful gut bacteria using precision viruses, opening the door to more personalized treatments for inflammatory bowel disease. (Georgia Kirkos, McMaster University) The work, published in Science Translational Medicine and highlighted on the journal’s cover, emerged...
Read more

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research.

-
Image
🌐 PhageAtLabs® — a global interactive mapping of academic laboratories in phage research. Take part in the project here: https://lnkd.in/e-csNChu   Support the project here: https://ko-fi.com/thephagetherapy PhageAtLabs® is currently under active development by The Phage Therapy team, with the aim of launching the platform this summer. At this stage, we are actively collecting information to ensure the platform is as complete and accurate as possible. For this reason, we kindly encourage you to share this form as widely as possible with laboratories, research groups, and colleagues working on bacteriophages that you know. This initiative is dedicated to building an interactive global map of academic laboratories and research groups working on bacteriophages. The goal is to create a structured and continuously updated database that brings together universities, institutes, and research teams involved in phage science worldwide. While similar initiatives exist in the broader ecosy...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Groundbreaking achievement : Phagos raises €25m to end bacterial disease

-
Image
 Phagos raises €25m to end bacterial disease  The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil  ● Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology and AI, Phagos offers the first phage-based drugs for veterinary use, a market worth tens of billions of dollars. The company plans to expand further as phage therapy becomes accepted in human health.                              ● The funding round was co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter alongside Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.  ● Objectives: deploy veterinary treatments in the field, develop the next generation of pat...
Read more